162 related articles for article (PubMed ID: 9725048)
21. [5-Fluorouracil level and pyrimidine nucleoside phosphorylase activity in cancer patients after oral administration of doxifluridine (5'-DFUR)].
Maeda H; Miyamoto T; Mochinaga N; Tsunoda T
Gan To Kagaku Ryoho; 1991 May; 18(6):965-9. PubMed ID: 1827573
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of acyclothymidine, a potent pyrimidine nucleoside phosphorylase inhibitor, on the pharmacokinetics of doxifluridine in rabbits via oral administration.
Hamada A; Fukushima S; Morinaga A; Saneyoshi M; Kawaguchi T; Nakano M
Biol Pharm Bull; 1993 Dec; 16(12):1297-300. PubMed ID: 8130783
[TBL] [Abstract][Full Text] [Related]
23. [Study of PyNPase activity in patients with gastric cancer--the association with preoperative IAP values].
Kirita T; Hamano K; Mabuchi G; Seshimo A; Kawase A; Miyashita M; Inada N
Gan To Kagaku Ryoho; 1995 Mar; 22(4):509-14. PubMed ID: 7887642
[TBL] [Abstract][Full Text] [Related]
24. Pyrimidine nucleoside phosphorylase and dihydropyrimidine dihydrogenase activities as predictive factors for the efficacy of doxifluridine together with mitomycin C as adjuvant chemotherapy in primary colorectal cancer.
Nishioka M; Miyamoto H; Kurita N; Higashijima J; Yoshikawa K; Miyatani T; Shimada M
Hepatogastroenterology; 2007 Jun; 54(76):1089-93. PubMed ID: 17629045
[TBL] [Abstract][Full Text] [Related]
25. Effects of introduction of dThdPase cDNA on sensitivity to 5'-deoxy-5-fluorouridine and tumor angiogenesis.
Kim R; Murakami S; Toge T
Int J Oncol; 2003 Apr; 22(4):835-41. PubMed ID: 12632076
[TBL] [Abstract][Full Text] [Related]
26. [PyNPase and DPD expression potentially predict response to 5'-DFUR treatment for node-positive breast cancer patients].
Akao S; Inoue K
Gan To Kagaku Ryoho; 2003 Sep; 30(9):1361-4. PubMed ID: 14518422
[TBL] [Abstract][Full Text] [Related]
27. [5'-Deoxy-5-fluorouridine enzymatic activation from the masked compound to 5-fluorouracil in human malignant tissues].
Hara Y
Gan To Kagaku Ryoho; 1984 Oct; 11(10):2133-43. PubMed ID: 6237613
[TBL] [Abstract][Full Text] [Related]
28. [A study of preoperative administration of 5'-DFUR in patients with colo-rectal cancer].
Haruta A; Umeno T; Tanaka S; Toriya H; Jyozaki H; Ikeda S
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2427-30. PubMed ID: 7944487
[TBL] [Abstract][Full Text] [Related]
29. [A case of multiple liver metastases of colon cancer with PyNPase-positive successfully treated with 5'-DFUR].
Maruyama S; Tamiya Y; Nihei K; Kitami C
Gan To Kagaku Ryoho; 2003 Oct; 30(10):1511-4. PubMed ID: 14584287
[TBL] [Abstract][Full Text] [Related]
30. [PyNPase activity in primary and metastatic colorectal cancer].
Kameyama M; Nakamori S; Imaoka S; Yasuda T; Ohigashi H; Hiratsuka M; Sasaki Y; Kabuto T; Ishikawa O; Furukawa H; Iwanaga T; Yokouchi H; Doi O
Gan To Kagaku Ryoho; 1997 Mar; 24(5):563-7. PubMed ID: 9087288
[TBL] [Abstract][Full Text] [Related]
31. [Study on the relationship between concentrations of 5-FU and PyNPase activity in tumor tissue during oral 5'-DFUR treatment in patients with advanced colorectal cancer].
Watanabe K; Igarashi T; Suzuki M; Hayashi T; Yoshida K; Hanyu F
Gan To Kagaku Ryoho; 1994 Feb; 21(2):243-8. PubMed ID: 8311496
[TBL] [Abstract][Full Text] [Related]
32. Clinical relevance of the concentrations of both pyrimidine nucleoside phosphorylase (PyNPase) and dihydropyrimidine dehydrogenase (DPD) in colorectal cancer.
Hiroyasu S; Shiraishi M; Samura H; Tokashiki H; Shimoji H; Isa T; Muto Y
Jpn J Clin Oncol; 2001 Feb; 31(2):65-8. PubMed ID: 11302344
[TBL] [Abstract][Full Text] [Related]
33. [Pyrimidine nucleoside phosphorylase activity, 5-fluorouracil concentration and thymidylate synthase inhibition rate in colorectal cancer after oral administration of 5'-doxifluridine].
Tomoda H; Morita M; Matsuoka H; Baba H; Taketomi A; Kohnoe S; Seo Y; Saito T
Gan To Kagaku Ryoho; 1997 Jun; 24(8):971-4. PubMed ID: 9212806
[TBL] [Abstract][Full Text] [Related]
34. High level concentration of pyrimidine nucleoside phosphorylase in esophageal squamous cell carcinoma but no correlation with clinicopathological parameters.
Noguchi T; Moriyama H; Wada S; Takeno S; Kimura Y; Uchida Y; Gabbert HE
Dis Esophagus; 2003; 16(4):307-11. PubMed ID: 14641294
[TBL] [Abstract][Full Text] [Related]
35. [Thymidine phosphorylase expressed in monocyte-macrophages enhanced anticancer effect of 5'-deoxy-5-fluorouridine on colorectal carcinoma cells].
Zhang JM; Liu MJ; Mizoi T; Shiiba K; Sasak I; Matsuno S
Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):718-24. PubMed ID: 15200906
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of antitumor activity of 5'-deoxy-5-fluorouridine (Furtulon) by taxane in human gastric cancer xenografts.
Sawada N; Nose T; Ishikawa T; Yutaka T
Oncol Rep; 2005 Jul; 14(1):53-7. PubMed ID: 15944767
[TBL] [Abstract][Full Text] [Related]
37. Induction of thymidine phosphorylase expression and enhancement of efficacy of capecitabine or 5'-deoxy-5-fluorouridine by cyclophosphamide in mammary tumor models.
Endo M; Shinbori N; Fukase Y; Sawada N; Ishikawa T; Ishitsuka H; Tanaka Y
Int J Cancer; 1999 Sep; 83(1):127-34. PubMed ID: 10449619
[TBL] [Abstract][Full Text] [Related]
38. Correlation between expression levels of thymidine phosphorylase (dThdPase) and clinical features in human gastric carcinoma.
Kimura H; Konishi K; Kaji M; Maeda K; Yabushita K; Miwa A
Hepatogastroenterology; 2002; 49(45):882-6. PubMed ID: 12064013
[TBL] [Abstract][Full Text] [Related]
39. Pyrimidine nucleoside phosphorylase activity in normal tissues of the uterus and ovary and in benign and malignant lesions of these organs.
Suzuki M; Usui N; Furugen Y; Mitsuhasi N
Int J Clin Oncol; 2001 Feb; 6(1):19-24. PubMed ID: 11706522
[TBL] [Abstract][Full Text] [Related]
40. [Conversion of 5'-deoxy-5-fluorouridine to 5-FU by pyrimidine nucleoside phosphorylases in normal and tumor tissues from rodents bearing tumors and cancer patients].
Miwa M; Nishimura J; Kamiyama T; Ishitsuka H
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2924-9. PubMed ID: 2959206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
